Literature DB >> 1595965

Indocyanine green disposition in healthy dogs and dogs with mild, moderate, or severe dimethylnitrosamine-induced hepatic disease.

D M Boothe1, S A Brown, W L Jenkins, R A Green, J M Cullen, D E Corrier.   

Abstract

Disposition kinetics of indocyanine green (ICG) were used to evaluate hepatic function in healthy Beagles (group 1; n = 6) and Beagles with progressive hepatic disease induced by oral administration of dimethylnitrosamine, a hepatospecific toxin. Three classes of hepatic disease were defined by histologic features: mild (group 2; n = 5), moderate (group 3; n = 6), and severe (group 4; n = 5). Disposition of ICG was studied 3 weeks following the last dose of toxin. A rapid IV injection of 0.5 mg of ICG/kg was administered and serum samples were obtained at certain intervals during 60-minute periods. Serum ICG was analyzed by use of visible spectrophotometry. Disposition kinetics were determined from serum ICG concentrations vs 15- and 60-minute time curves and compared between one another and among groups. Data based on 60-minute time curves were not significantly different from those based on 15-minute curves. Area under the curve for ICG was greatest in group 3. Clearance of ICG was decreased and mean resident time was increased in groups 3 and 4, compared with those in groups 1 and 2. When disposition data (60 minutes) were normalized for differences in hepatic weight among dogs, group-3 mean resident time was significantly greater than that of group 4. This study supports the diagnostic benefits of using ICG disposition kinetics as a method of evaluating hepatic function in dogs with progressive liver disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1595965

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  2 in total

1.  A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow-derived cells.

Authors:  Takashi Matsuda; Taro Takami; Ryo Sasaki; Tatsuro Nishimura; Yuki Aibe; Bruno Diaz Paredes; Luiz Fernando Quintanilha; Toshihiko Matsumoto; Tsuyoshi Ishikawa; Naoki Yamamoto; Kenji Tani; Shuji Terai; Yasuho Taura; Isao Sakaida
Journal:  Hepatol Commun       Date:  2017-07-17

2.  Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model.

Authors:  Tatsuro Nishimura; Taro Takami; Ryo Sasaki; Yuki Aibe; Takashi Matsuda; Koichi Fujisawa; Toshihiko Matsumoto; Naoki Yamamoto; Kenji Tani; Yasuho Taura; Isao Sakaida
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.